LYVE-1, the lymphatic system and tumor lymphangiogenesis
- 1 June 2001
- journal article
- review article
- Published by Elsevier in Trends in Immunology
- Vol. 22 (6), 317-321
- https://doi.org/10.1016/s1471-4906(01)01936-6
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Mouse LYVE-1 Is an Endocytic Receptor for Hyaluronan in Lymphatic EndotheliumJournal of Biological Chemistry, 2001
- Identification of CD44 Residues Important for Hyaluronan Binding and Delineation of the Binding SiteJournal of Biological Chemistry, 1998
- Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD44.Journal of Clinical Investigation, 1996
- Solution Structure of the Link Module: A Hyaluronan-Binding Domain Involved in Extracellular Matrix Stability and Cell MigrationCell, 1996
- CD44 and hyaluronan-dependent rolling interactions of lymphocytes on tonsillar stroma.The Journal of cell biology, 1996
- The protein fold of the hyaluronate‐binding proteoglycan tandem repeat domain of link protein, aggrecan and CD44 is similar to that of the C‐type lectin superfamilyFEBS Letters, 1996
- Administration of Antibodies to Hyaluronanreceptor (CD44) Delays the Start and Ameliorates the Severity of Collagen II ArthritisScandinavian Journal of Immunology, 1995
- Identification of hyaluronic acid binding sites in the extracellular domain of CD44The Journal of cell biology, 1993
- Hyaluronate activation of CD44 induces insulin-like growth factor-1 expression by a tumor necrosis factor-alpha-dependent mechanism in murine macrophages.Journal of Clinical Investigation, 1993
- CD44 is the principal cell surface receptor for hyaluronateCell, 1990